|
Elenco pubblicazioni 2008-2009
- P. Rovere-Querini, S. Brunelli, E. Clementi, and A.A. Manfredi. Cell death: tipping the balance of autoimmunity and tissue repair. Curr. Pharm. Des. 3: 269-277, 2008
I.F. 5.27
- C. De Palma, S. Falcone, C. Panzeri, S. Radice, M.T. Bassi, and E. Clementi. Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: a link between inflammation and neuroprotection. J. Neurochem. 106: 193-204, 2008
I.F. 2.84
- C. Perrotta, C. De Palma, and E. Clementi. Nitric oxide and sphingolipids: mechanisms of interaction and role in cellular pathophysiology. Biol. Chem. 389: 1391-1397, 2008
I.F. 2.84
- E. Clementi, and A.A. Manfredi. The immune system facing injured tissues and stem cells: More of a healer or a fighter? Pharmacol. Res. 58: 87, 2008
I.F. 2.4
- C. Colussi, C. Mozzeta, A. Gurtner, B. Illi, J. Rossi, S. Straino, G. Ragone, M. Pescatori, G. Zaccagnini, A. Antonini, G. Minetti, F. Martelli, G. Piaggio, P. Gallinari, C. Steinkluher, E. Clementi, C. Dell’Aversana, L. Altucci, A. Mai, M.C. Capogrossi, P.L. Puri, and C. Gaetano. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc. Natl. Acad. Sci. USA 105: 19183-19187, 2008
I.F. : 9,38
- Cattaneo D, Bitto A, Baldelli S, Cortinovis M, Perico N, Gotti E, Remuzzi G. “Pharmacokinetic/pharmacodynamic interaction between rosiglitazone and mycophenolate mofetil in kidney transplantation: a case report”. Transplantation 2008, 85:921-922.
I.F. : 3,816
- Cattaneo D. Pharmacokinetics and pharmacodynamics of mycophenolic acid: different formulations in stable renal transplant patients. Trends in Transplantation2008, 2:51-61.
I.F. : 9.90
- Cattaneo D, Perico N, Remuzzi G. Determination of atazanavir in human plasma by high performance liquid chromatography with ultraviolet detection. J Chrom Sci, 2008, 46:485-489 .
I.F. : 1,323
- Cattaneo D. Pharmacogenetics of immunosuppressants and clinical outcome. Pharmacogenomics 2008, 9:1191-1194.
I.F. : 3,551
- de Winter BCM, van Gelder T, Budde K, Cattaneo D, Tedesco-Silva H, Neumann I, Hilbrands L, van Hest RM, Pescovitz MD, Mathot RAA. Population pharmacokinetic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients. Clinical Pharmacokinetics, 2008;47:827-38
I.F. : 4,206
- Cortinovis M, Cattaneo D, Perico N, Remuzzi G. Investigational drugs for diabetic nephropathy. Exp Opin Invest Drugs 2008, 17:1487-1500.
I.F. : 3,667
- Remuzzi G, Cattaneo D, Perico N. The aggravating mechanisms of aldosterone on kidney fibrosis. J Am Soc Nephrol,2008;19:1459-62.
I.F. : 7,505
- Cattaneo D, Baldelli S, Perico N. Pharmacogenetics of immunosuppressants; progress, promises and pitfalls. Am J Transplant, 2008;8:1374-83.
I.F. : 6.559
- Frontini A, Bertolotti P, Tonello C, Valerio A, Nisoli E, Cinti S, Giordano A. Leptin-dependent STAT3 phosphorylation in postnatal mouse hypothalamus. Brain Res. 2008 Jun 18;1215:105-115.
I.F. : 2,49
- C. Donati, F. Cencetti, C. De Palma, E. Rapizzi, S. Brunelli, G. Cossu, E. Clementi, and P. Bruni. TGFb protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation. Cell Signal. 21: 228-236, 2009
I.F. : 4,30
- C. Sciorati, T. Touvier, R. Buono, P. Pessina, S. François, C. Perrotta, R. Meneveri, E. Clementi, and S. Brunelli. Necdin is expressed in cachectic muscle to protect fibers from tumor-induced apoptosis. J. Cell Sci. 122: 1119-1125, 2009.
I.F. : 6,24
- K. Lolmede, L. Campana, M. Vezzoli, L. Bosurgi, R. Tonlorenzi, E. Clementi, M.E. Bianchi, G. Cossu, A.A. Manfredi, S. Brunelli, and P. Rovere-Querini. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J. Leukoc. Biol. 85: 779-787, 2009
I.F. : 4,60
- C. Vantaggiato, F. Redaelli, S. Falcone, C. Perrotta, A. Tonelli, S. Bondioni, M. Morbin, D. Riva, V. Saletti, M.C. Bonaglia, R. Giorda, N. Bresolin, E. Clementi, M.T. Bassi. A novel CLN8 mutation in late-infantile-onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological function. Hum. Mutat. 30: 1-13, 2009
I.F. : 7,03
- F. Bianco, C. Perrotta, L. Novellino, M. Francolini, L. Riganti, E. Menna, L. Saglieti, E. H. Schuchman, R. Furlan, E. Clementi, M. Matteoli, and C. Verderio. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 28: 1043-1054, 2009.
I.F. : 8,90
- C. De Palma, R. Di Paola, C. Perrotta, E. Mazzon, D. Cattaneo, E. Trabucchi, S. Cuzzocrea, and E. Clementi. Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects. Pharmacol. Res. 60: 221-228, 2009
I.F.: 3.29
- C. Colussi, A. Gurtner, J. Rosati, B. Illi, G. Ragone, G. Piaggio, M. Moggio, C. Lamperti, G. D'Angelo, E. Clementi, G. Minetti, C. Mozzetta, A. Antonini, M. C. Capogrossi, P. L. Puri, C. Gaetano Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy. FASEB J. 23: 2131–2141, 2009
I.F. : 7,12
- D. Deponti, R. Buono, G. Catanzaro, C. De Palma, R. Longhi, R. Meneveri, N. Bresolin, M. T. Bassi, G. Cossu, E. Clementi, and S. Brunelli. The Low Affinity Receptor for Neurotrophins p75NTR Plays a Key Role for Satellite Cell Function in Muscle Repair Acting via RhoA. Mol. Biol. Cell, 20: 3620–3627, 2009
I.F. : 5,55
- Corsi F, De Palma C, Colombo M, Allevi R, Nebuloni M, Ronchi S, Rizzi G, Tosoni A, Trabucchi E, Clementi E, Prosperi D. Towards Ideal Magnetofluorescent Nanoparticles for Bimodal Detection of Breast-Cancer Cells. Small 5: 2555-2564, 2009
I.F. : 6,55
- Airoldi G, Guidarelli A, Cantoni O, Panzeri C, Vantaggiato C, Bonato S, Grazia D'Angelo M, Falcone S, De Palma C, Tonelli A, Crimella C, Bondioni S, Bresolin N, Clementi E, Bassi MT. Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin. Neurogenetics 2009 Jul 11. [Epub ahead of print]
I.F.: 3.28
- Oteri A, Cattaneo MT, Filipazzi V, Ferrario S, Gambaro A, Isabella L, Tosca N, Clementi E, Radice S, Piazza E. A case of bullous dermatitis induced by erlotinib. Oncologist. 14:1201-1204, 2009
I.F.: 6.63
- Perico N, Cattaneo D, Remuzzi G. KIM-1: in search of biomarkers of chronic tubulointerstitial damage and disease progression. Am J Kidney Dis 2009 53:1-4.
I.F. : 4,822
- Perico N, Cattaneo D, Bikbov B, Remuzzi G. Hepatitis C and chronic kidney diseases. CJASN 2009;4:207-20.
I.F. : 4,361
- Ripamonti D, Cattaneo D, Cortinovis M, Maggiolo F, Suter F. Transplacental passage of ritonavir-boosted darunavir in two pregnant women. Int J STD AIDS. 2009;20:215-6.
I.F. : 1,300
- Cattaneo D, Ruggenenti P, Baldelli S, Motterlini N,. Gotti E, Sandrini S, Salvadori S, Segoloni G, Rigotti P, Donati D, Remuzzi G. ABCB1 genotypes predict cyclosporine-related adverse events and graft outcome in kidney transplantation. J Am Soc Nephrol 2009;20:1404-1415.
I.F. : 7,505
- Cattaneo D, Cortinovis M, Baldelli S, Gotti E, Remuzzi G, Perico N. Limited sampling strategies for the estimation of sirolimus exposure in kidney transplant recipients on calcineurin inhibitor-free regimen. J Clin Pharmacol 2009; 49:773-781.
I.F. : 3,134
- Ruggenenti P, Cattaneo D, Loriga G, Ledda F, Motterlini N, Ghepardi G, Orisio S, Remuzzi G. Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy. Hypertension, 2009;54:567-74
I.F. : 7,368
- Cortinovis M, Perico N, Cattaneo D, Baldelli S, Gotti E, Remuzzi G. Omega-3 polyunsaturated fatty acids affect sirolimus exposure in kidney transplant recipients on calcineurin inhibitor-free regimen. Transplantation 2010;89:126-7
I.F. : 3,816
- Kuypers D, Le Meur Y, Cantarovich M, Tredger M, Tett S, Cattaneo D, Burkhard T, Holt DW, Chapman J, Van Gelder T. Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. CJASN epub ahead of print.
I.F. : 4,361
|